CVAC
CureVac N.V.
Set alert
4.66 USD 0.00 0.00%
4.57 Day range 4.66
4.00 52-week range 5.55
- YTD
- +3.10%
- 1 year
- +28.73%
- Open
- 4.57
- Prev close
- 4.66
- Mkt cap
- 1.05B
- Vol
- 728.78K
- Avg vol
- 1.76M
- EPS
- 0.72
- P/E
- 4.39
- Div yield
- 0.00%
More statistics
- Low
- 4.57
- High
- 4.66
- Beta
- 1.84
- Inst. own
- 10.42%
- Dividend
- 0.00
Financial health
Altman Z-Score
1.79 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E 4.6×
FY 2018 5y median -4.3× FY 2024
P/S 1.4×
FY 2018 5y median 15.8× FY 2024
P/B 1.1×
FY 2018 5y median 2.0× FY 2024
P/FCF 8.9×
FY 2018 5y median -2.6× FY 2024
EV/EBITDA 1.4×
FY 2018 5y median -2.8× FY 2024
EV/Sales 0.6×
FY 2018 5y median 9.1× FY 2024
FCF Yield 11.3%
FY 2018 5y median -15.3% FY 2024
Profitability
Gross Margin 80.2%
FY 2018 5y median -131.3% FY 2024
Operating Margin 33.2%
FY 2018 5y median -370.0% FY 2024
Net Margin 30.3%
FY 2018 5y median -369.4% FY 2024
ROE 23.3%
FY 2018 5y median -46.7% FY 2024
ROIC 20.5%
FY 2018 5y median -35.2% FY 2024
ROA 20.2%
FY 2018 5y median -28.9% FY 2024
Growth (YoY)
Revenue 895.5%
FY 2018 FY 2024
Operating Income 164.8%
FY 2018 FY 2024
EPS (diluted) 161.0%
FY 2018 FY 2024
Free Cash Flow 125.8%
FY 2018 FY 2024
Financial Health
Current Ratio 7.3×
FY 2018 5y median 3.7× FY 2024
Quick Ratio 7.3×
FY 2018 5y median 3.6× FY 2024
Debt / Equity 0.1×
FY 2018 5y median 0.1× FY 2024
Net Debt / EBITDA -2.1×
FY 2018 5y median 2.0× FY 2024
Interest Coverage 0.0×
FY 2018 5y median -39.9× FY 2024
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2024-12-31